Equity (Tables)
|
12 Months Ended |
Dec. 31, 2023 |
| Share-Based Payment Arrangements [Abstract] |
|
| Schedule of Share-Based Compensation |
| | | | | | | | | | | | | Share-based compensation | December 31, 2023 | | December 31, 2022 | | Option Expense | $ | 3,035 | | | $ | 5,931 | | | DSU Expense | 397 | | | 529 | | | RSU Expense | 7,288 | | | 2,479 | | | Total share-based compensation for continuing operations (per statement of loss) | $ | 10,720 | | | $ | 8,939 | | | Discontinued operations | 239 | | | 469 | | | Total share-based compensation (per statement of equity) | $ | 10,959 | | | $ | 9,408 | |
|
| Schedule of Number and Weighted Average Exercise Prices of Share Options |
As at December 31, options outstanding from the consolidated share option plan were as follows: | | | | | | | | | | | | | Balance | Options for common shares | | Weighted average exercise price | | At January 1, 2022 | 4,041,567 | | | $ | 8.70 | | | Options granted | 1,263,685 | | | 8.97 | | | Options exercised | (304,635) | | | 2.87 | | | Options forfeited | (184,496) | | | 12.75 | | | Options expired | (8,501) | | | 2.20 | | | At December 31, 2022 | 4,807,620 | | | 9.19 | | | | | | | Options exercised | (152,120) | | | 2.25 | | | Options forfeited | (263,253) | | | 10.39 | | | Options expired | (2,025) | | | 1.36 | | | At December 31, 2023 | 4,390,222 | | | $ | 9.36 | |
|
| Schedule of Number and Weighted Average Remaining Contractual Life of Outstanding Share Options |
The following table summarizes information about the Corporation’s share options outstanding as at December 31, 2023: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | Options outstanding | | Options exercisable | | Number | | Weighted average remaining contractual life | | Weighted average exercise | | Number | | Weighted average | | Range of exercise price | outstanding | | (years) | | price | | exercisable | | exercise price | $1.33 - $3.08 | 1,038,671 | | | 1.7 | | $ | 2.84 | | | 1,038,671 | | | $ | 2.84 | | $3.64 - $5.62 | 440,140 | | | 2.1 | | 4.05 | | | 393,037 | | | 3.86 | | $7.07 - $10.73 | 2,043,418 | | | 4.2 | | 10.14 | | | 1,403,784 | | | 10.43 | | $12.91 - $26.13 | 867,993 | | | 4.1 | | 18.02 | | | 729,625 | | | 17.43 | | | 4,390,222 | | | 3.4 | | $ | 9.36 | | | 3,565,117 | | | $ | 8.93 | |
|
| Schedule of Range of Exercise Prices of Outstanding Share Options |
The following table summarizes information about the Corporation’s share options outstanding as at December 31, 2023: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | Options outstanding | | Options exercisable | | Number | | Weighted average remaining contractual life | | Weighted average exercise | | Number | | Weighted average | | Range of exercise price | outstanding | | (years) | | price | | exercisable | | exercise price | $1.33 - $3.08 | 1,038,671 | | | 1.7 | | $ | 2.84 | | | 1,038,671 | | | $ | 2.84 | | $3.64 - $5.62 | 440,140 | | | 2.1 | | 4.05 | | | 393,037 | | | 3.86 | | $7.07 - $10.73 | 2,043,418 | | | 4.2 | | 10.14 | | | 1,403,784 | | | 10.43 | | $12.91 - $26.13 | 867,993 | | | 4.1 | | 18.02 | | | 729,625 | | | 17.43 | | | 4,390,222 | | | 3.4 | | $ | 9.36 | | | 3,565,117 | | | $ | 8.93 | |
|
| Schedule of Number and Weighted Average Exercise Prices of Other Equity Instruments |
| | | | | | | Balance | DSUs for common shares | | At January 1, 2022 | 756,223 | | | DSUs granted | 80,319 | | | DSUs exercised | (126,862) | | | At December 31, 2022 | 709,680 | | | DSUs granted | 93,188 | | | DSUs exercised | (65,499) | | | At December 31, 2023 | 737,369 | |
| | | | | | | Balance | RSUs for common shares | | At January 1, 2022 | 966,220 | | | RSUs granted | 567,693 | | | RSU performance factor adjustment | (29,004) | | | RSUs exercised | (460,681) | | | RSUs forfeited | (42,148) | | | At December 31, 2022 | 1,002,080 | | | RSUs granted | 2,996,387 | | | | | RSUs exercised | (279,668) | | | RSUs forfeited | (577,353) | | | At December 31, 2023 | 3,141,446 | |
|